About Fitusiran
Class: | Antisense oligonucleotide therapy
Use: | Treatment of hemophilia A or B in patients with inhibitors to factor VIII or IX
Adult dose: | 50 mg subcutaneously once every 4 weeks
Pediatric dose: | Safety and efficacy not established in pediatric patients under 12 years of age; dosing for patients 12 years and older is the same as adults
Side effects: | Injection site reactions, headache, nausea, fatigue, and potential for thromboembolic events
Contraindications: | Hypersensitivity
Drug Class
Antisense oligonucleotide therapy
Uses & Indications
Treatment of hemophilia A or B in patients with inhibitors to factor VIII or IX
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for up to 30 days
Manufacturer & Packaging
Manufacturer: Genzyme, U.S.A
Package Size
1 Glass Vial (0.2 mL)
Price & Supplier
Price in UAE: AED 347188.50
Dosage Information
Adult Dose
50 mg subcutaneously once every 4 weeks
Pediatric Dose
Safety and efficacy not established in pediatric patients under 12 years of age; dosing for patients 12 years and older is the same as adults
Side Effects
Injection site reactions, headache, nausea, fatigue, and potential for thromboembolic events
Contraindications & Precautions
Hypersensitivity to fitusiran or any component of the formulation; active thrombosis
Important Warnings
Risk of thrombosis; monitor for signs of thromboembolic events; not recommended for use in patients with severe renal impairment or active liver disease
Related Medicines in Same Category
See also: Other Antisense oligonucleotide therapy medicines available in UAE pharmacies
NIROGACESTAT
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.